Patent applications and USPTO patent grants for Xintela AB.The latest application filed is for "detection and treatment of malignant tumours in the cns".
Patent | Date |
---|---|
Detection and Treatment of Malignant Tumours in the CNS App 20210316005 - Lundgren kerlund; Evy ;   et al. | 2021-10-14 |
Detection and treatment of malignant tumours in the CNS Grant 10,994,022 - Lundgren-.ANG.kerlund , et al. May 4, 2 | 2021-05-04 |
Quality Assurance Of Chondrocytes App 20200377858 - Lundgren kerlund; Evy ;   et al. | 2020-12-03 |
Quality assurance of chondrocytes Grant 10,781,424 - Lundgren .ANG.kerlund , et al. Sept | 2020-09-22 |
Prevention and treatment of bone and cartilage damage or disease App 20200038449 - Lundgren kerlund; Evy ;   et al. | 2020-02-06 |
Marker for Neural Stem Cells App 20190369093 - LUNDGREN KERLUND; Evy ;   et al. | 2019-12-05 |
Quality Assurance of Chondrocytes App 20190300855 - Lundgren kerlund; Evy ;   et al. | 2019-10-03 |
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Grant 10,087,253 - Lundgren-Akerlund October 2, 2 | 2018-10-02 |
Integrin heterodimer and a subunit thereof Grant 10,081,666 - Lundgren-Akerlund September 25, 2 | 2018-09-25 |
Detection and treatment of malignant tumours in the CNS App 20180236094 - Lundgren- kerlund; Evy ;   et al. | 2018-08-23 |
Integrin Heterodimer And A Subunit Thereof App 20180079795 - LUNDGREN-AKERLUND; Evy | 2018-03-22 |
Integrin Heterodimer And A Subunit Thereof App 20170121386 - LUNDGREN-AKERLUND; Evy | 2017-05-04 |
Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1 App 20160319023 - Lundgren-Akerlund; Evy | 2016-11-03 |
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Grant 9,365,649 - Lundgren- kerlund June 14, 2 | 2016-06-14 |
Integrin heterodimer and a subunit thereof Grant 8,895,253 - Lundgren-Akerlund November 25, 2 | 2014-11-25 |
Monoclonal Antibody Capable Of Binding Integrin Alpha 10 Beta 1 App 20140099716 - Lundgren-Akerlund; Evy | 2014-04-10 |
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Grant 8,563,255 - Lundgren-Akerlund October 22, 2 | 2013-10-22 |
Integrin Heterodimer And A Subunit Thereof App 20130137118 - LUNDGREN-AKERLUND; Evy | 2013-05-30 |
Integrin Heterodimer And A Subunit Thereof App 20120136141 - Lundgren-Akerlund; Evy | 2012-05-31 |
Monoclonal Antibody Capable of Binding Integrin Alpha 10 Beta 1 App 20120034625 - Lundgren-Akerlund; Evy | 2012-02-09 |
Marker for stem cells and its use Grant 8,105,791 - Lundgren-.ANG.kerlund January 31, 2 | 2012-01-31 |
Antibody to an integrin heterodimer and/or a subunit thereof Grant 8,048,991 - Lundgren-.ANG.kerlund November 1, 2 | 2011-11-01 |
Monoclonal antibody capable of binding integrin alpha 10 beta 1 Grant 8,012,696 - Lundgren-.ANG.kerlund September 6, 2 | 2011-09-06 |
Marker For Stem Cells And Its Use App 20110033923 - Lundgren-Akerlund; Evy | 2011-02-10 |
Marker for stem cells and its use Grant 7,749,710 - Lundgren-.ANG.kerlund July 6, 2 | 2010-07-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.